Paragonix Partners with NORA to Launch Equitable Donor Organ Courier Service

Organ preservation company Paragonix Technologies has partnered with the US Nationwide Organ Recovery Transport Alliance (NORA) to launch a donor organ courier service aimed at ensuring equitable distribution of organs across the country. This collaboration combines Paragonix’s advanced organ preservation devices with NORA’s logistic expertise and commercial flight networks to enhance organ delivery efficiency.

Lisa Anderson, CEO of Paragonix, emphasized the transformative potential of commercial air travel for organ transportation, noting that it reduces costs and lowers environmental impact by minimizing reliance on private jets. Anderson highlighted that this shift could be one of the most significant environmental improvements in organ transplantation logistics.

The partnership follows the enactment of the Federal Aviation Administration Reauthorization Act, which introduced guidelines for transporting donor organs in the main cabin of commercial planes. One of the key technologies involved is Paragonix’s BAROguard Donor Lung Preservation System, supported by NORA's Care-Custody-Control program to handle customs and logistics.

Don Jones, Co-Founder of NORA, expressed excitement about the innovation, noting that they have never seen lungs transported via commercial flights using advanced preservation methods before. This collaboration aims to improve equity in organ access nationwide, utilizing cutting-edge preservation technologies like Paragonix’s PancreasPak, the first FDA-cleared pancreas preservation system.

Paragonix also recently announced the successful completion of the GUARDIAN-Heart trial, further solidifying its position as a leader in organ preservation technology.